Anmeldung erfolgt in Kürze...
Details werden geladen...
Calidi Biotherapeutics Reports Inducement Grant Under NYSE American LLC Company Guide Section 711 | The Manila Times
SAN DIEGO, July 08, 2026 (GLOBE NEWSWIRE) -- Calidi Biotherapeutics Inc. (NYSE American: CLDI) ('Calidi”), a biotechnology company pioneering the development of targeted genetic medicine, today announced that in connection with the appointment of Sandra Gurrola as VP Finance, Controller, the Company’s Compensation Committee and the Board of Directors has approved the grant of an inducement non-qualified stock option for Ms. Gurrola for the purchase of 100,000 shares with an exercise price of $0.15, which was the closing price of the Company’s common stock on July 6, 2026, the date of grant (the 'Stock Options”).
Ähnliche Seiten
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/20/tmt-newswire/globenewswire/ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635c4/2369285
Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/05/23/tmt-newswire/globenewswire/ultragenyx-reports-inducement-grant-under-nasdaq-listing-rule-5635c4/2350373Vor Bio Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/02/tmt-newswire/globenewswire/vor-bio-reports-inducement-grant-under-nasdaq-listing-rule-5635c4/2356286CAMP4 Therapeutics Announces Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/20/tmt-newswire/globenewswire/camp4-therapeutics-announces-inducement-grants-under-nasdaq-listing-rule-5635c4/2369284Olema Oncology Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) | The Manila Times
https://www.manilatimes.net/2026/06/03/tmt-newswire/globenewswire/olema-oncology-reports-inducement-grants-under-nasdaq-listing-rule-5635c4/2357328